Sodium Chlorode Hypertonicity Ophthalmic Solution
NDC Package 0536-1254-94
Package Information
Sodium Chlorode Hypertonicity Ophthalmic Solution (sodium chloride) solution is a medication used to treat dryness inside the nose (nasal passages). This formulation utilizes a solution delivery system. Marketed by Rugby Laboratories, this product is identified by NDC 0536-1254 and is authorized under FDA application M018.
Identification & Billing
- RxCUI: 730780 - sodium chloride 5 % Ophthalmic Solution
- RxCUI: 730780 - sodium chloride 0.854 MEQ/ML Ophthalmic Solution
- RxCUI: 730780 - NaCl 0.854 MEQ/ML Ophthalmic Solution
- RxCUI: 730780 - NaCl 5 % Ophthalmic Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0536 - Rugby Laboratories
- 0536-1254 - Sodium Chlorode Hypertonicity Ophthalmic Solution
- 0536-1254-94 - 1 BOTTLE in 1 CARTON / 15 mL in 1 BOTTLE
- 0536-1254 - Sodium Chlorode Hypertonicity Ophthalmic Solution
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0536-1254-94 identifies a specific commercial package of 1 bottle in 1 carton / 15 ml in 1 bottle of Sodium Chlorode Hypertonicity Ophthalmic Solution, a human over the counter drug labeled by Rugby Laboratories. This solution is formulated for ophthalmic use and contains sodium chloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Rugby Laboratories on September 17, 2020. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This product is used to treat dryness inside the nose (nasal passages). It helps add moisture inside the nose to dissolve and soften thick or crusty mucus. In babies and young children with stuffy noses who cannot blow their noses, using this product helps to make the mucus easier to remove with a nasal bulb syringe. This helps relieve stuffiness and makes breathing easier. This product contains a purified gentle salt solution (also called saline or sodium chloride solution). It does not contain any medication.
How is this Rugby Laboratories product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00536125494. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.